Second-Line Treatment of Her2-Positive Metastatic Breast Cancer: Trastuzumab beyond Progression or Lapatinib? A Population Based Cohort Study

Por Hammerman, Ariel, Greenberg-Dotan, Sari, Feldhamer, Ilan, Bitterman, Haim, Yerushalmi, Rinat
Publicado no PLoS One (2015)

Oncologists’ and family physicians’ views on value for money of cancer and congestive heart failure care

Por Greenberg, Dan, Hammerman, Ariel, Vinker, Shlomo, Shani, Adi, Yermiahu, Yuval, Neumann, Peter J
Publicado em 2013

Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study

Por Leventer-Roberts, Maya, Hammerman, Ariel, Brufman, Ilan, Hoshen, Moshe, Braun, Marius, Ashur, Yaffa, Lieberman, Nicky, Balicer, Ran
Publicado no PLoS One (2017)

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis

Por Goldstein, Daniel A., Chen, Qiushi, Ayer, Turgay, Chan, Kelvin K. W., Virik, Kiran, Hammerman, Ariel, Brenner, Baruch, Flowers, Christopher R., Hall, Peter S.
Publicado no Oncologist (2017)